Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05829694 · ClinicalTrials.gov registry record
Health Outcomes of Parents With Cystic Fibrosis
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 956
- Enrollment target
NCT05829694: Completed study, sponsored by University of Pittsburgh.
NCT05829694 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 956 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05829694 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 956 participants
- Enrollment target
Study Summary
This project will determine the health impact of parenthood on people with cystic fibrosis (CF). The study team will use retrospective data to provide relatively immediate evidence on parenthood's effect on pulmonary health.
Primary Outcome
Rate of decline of ppFEV1 as reported in the CFFPR
Interventions
- OTHER Parental Status
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 956 participants |
| Start Date | 2023-07-12 |
| Est. Completion | 2024-08-12 |
What the finished NCT05829694 record still lists
NCT05829694 is an observational study that tracks outcomes without assigning an intervention. The registered 956 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Parental Status is the first listed.
NCT05829694 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05829694 about?
NCT05829694 is a clinical study titled "Health Outcomes of Parents With Cystic Fibrosis". This project will determine the health impact of parenthood on people with cystic fibrosis (CF). The study team will use retrospective data to provide relatively immediate evidence on parenthood's effect on pulmonary health.
What is the current status of trial NCT05829694?
This trial is currently completed. The enrollment target is 956 participants. The study started on 2023-07-12. Estimated completion is 2024-08-12.
What interventions are being tested in trial NCT05829694?
The interventions under investigation include: Parental Status (OTHER).
Who is sponsoring clinical trial NCT05829694?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06225596 · 956 participants · Phase 2
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
- NCT06259669 · 958 participants
Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
- NCT04726241 · 960 participants · Phase 1
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- NCT05142384 · 960 participants · NA
ICBT (Internet Based Cognitive Behavioral Therapy) for Maternal Depression: Community Implementation in Head Start
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI